These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Mulholland S; Gavranich JB; Chang AB Cochrane Database Syst Rev; 2010 Jul; (7):CD004875. PubMed ID: 20614439 [TBL] [Abstract][Full Text] [Related]
24. Evolution of acute infection with atypical bacteria in a prospective cohort of children with community-acquired pneumonia receiving amoxicillin. Nascimento-Carvalho CM; Xavier-Souza G; Vilas-Boas AL; Fontoura MH; Barral A; Puolakkainen M; Ruuskanen O; J Antimicrob Chemother; 2017 Aug; 72(8):2378-2384. PubMed ID: 28475737 [TBL] [Abstract][Full Text] [Related]
25. Community-acquired pneumonia in children. Dennehy PH Med Health R I; 2010 Jul; 93(7):211-5. PubMed ID: 20704068 [No Abstract] [Full Text] [Related]
26. Aetiology of community-acquired pneumonia: serological results of a paediatric survey. Don M; Fasoli L; Paldanius M; Vainionpää R; Kleemola M; Räty R; Leinonen M; Korppi M; Tenore A; Canciani M Scand J Infect Dis; 2005; 37(11-12):806-12. PubMed ID: 16308213 [TBL] [Abstract][Full Text] [Related]
30. Pneumonia in children. Berti I; Faraguna D N Engl J Med; 2002 Jun; 346(24):1916; author reply 1916. PubMed ID: 12063383 [No Abstract] [Full Text] [Related]
31. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Michelow IC; Olsen K; Lozano J; Rollins NK; Duffy LB; Ziegler T; Kauppila J; Leinonen M; McCracken GH Pediatrics; 2004 Apr; 113(4):701-7. PubMed ID: 15060215 [TBL] [Abstract][Full Text] [Related]
32. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin. Appelbaum PC; Gillespie SH; Burley CJ; Tillotson GS Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123 [TBL] [Abstract][Full Text] [Related]
33. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Gardiner SJ; Gavranich JB; Chang AB Cochrane Database Syst Rev; 2015 Jan; 1(1):CD004875. PubMed ID: 25566754 [TBL] [Abstract][Full Text] [Related]
34. Community-acquired pneumonia in infants and children. Ostapchuk M; Roberts DM; Haddy R Am Fam Physician; 2004 Sep; 70(5):899-908. PubMed ID: 15368729 [TBL] [Abstract][Full Text] [Related]
35. Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team. Mundy LM; Oldach D; Auwaerter PG; Gaydos CA; Moore RD; Bartlett JG; Quinn TC Chest; 1998 May; 113(5):1201-6. PubMed ID: 9596295 [TBL] [Abstract][Full Text] [Related]
36. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. Principi N; Esposito S; Blasi F; Allegra L; Clin Infect Dis; 2001 May; 32(9):1281-9. PubMed ID: 11303262 [TBL] [Abstract][Full Text] [Related]
37. [Epidemiological and clinical analysis of community-acquired Mycoplasma pneumonia in children from a Spanish population, 2010-2015]. Aguilera-Alonso D; López Ruiz R; Centeno Rubiano J; Morell García M; Valero García I; Ocete Mochón MD; Montesinos Sanchis E An Pediatr (Engl Ed); 2019 Jul; 91(1):21-29. PubMed ID: 30679135 [TBL] [Abstract][Full Text] [Related]